Engineered Virus Steals Proteins From H.I.V., Pointing to New …
WEBAug 8, 2024 · Scientists have developed a new weapon against H.I.V.: a molecular mimic that invades a cell and steals essential proteins from the virus. A study published in Science on Thursday reported...
New HIV drug can only offer hope of ending AIDS if all have …
WEBJul 10, 2024 · New HIV drug can only offer hope of ending AIDS if all have access, UNAIDS says. GENEVA, 10 July 2024— UNAIDS has welcomed the release of Gilead Sciences’ trial results on the injectable long-acting HIV medicine Lenacapavir for HIV prevention.
Twice-yearly shot proves successful at preventing HIV infection …
WEBJul 24, 2024 · Two shots a year of a drug currently used to treat HIV infections were dramatically effective at preventing infections in a study among young women and adolescent girls in Africa.
Researchers a step closer to a cure for HIV | ScienceDaily
WEBMar 26, 2024 · Researchers a step closer to a cure for HIV. A new study shows virus-like particle can effectively 'shock and kill' latent HIV reservoir in those living with chronic HIV. By 2030, the World...
After decades of failures, researchers have renewed hopes for an ...
WEBMar 6, 2024 · Despite 20 years of failures in major HIV vaccine trials, researchers say recent advances have likely, hopefully, put them on the right track to develop a highly effective vaccine.
A seventh case of HIV cure reported at AIDS 2024
WEBJul 25, 2024 · During the 25th International AIDS Conference (AIDS 2024), being held in Munich, Germany, a new case of long HIV remission was reported and fuels optimism for an eventual HIV cure.
News at a glance: Long-lasting HIV prevention, a new neutrino
WEB20 hours ago · The latest in science and policy. PUBLIC HEALTH Shots prevent HIV in at-risk men. A drug injected just twice a year has demonstrated a remarkable ability to thwart HIV infections in men who have sex with men, 3 months after it …
Long-Acting Drugs May Revolutionize H.I.V. Prevention and …
WEBApr 17, 2024 · The drug is in multiple late-stage trials as a long-acting H.I.V. preventative in various groups, including cisgender women. Lenacapavir is also being tested as a treatment in the form of a...
FDA Approves New HIV Drug for Adults with Limited Treatment …
WEBJan 4, 2023 · Sunlenca is the first of a new class of drugs called capsid inhibitors to be FDA-approved for treating HIV-1. Sunlenca works by blocking the HIV-1 virus’ protein shell (the capsid), thereby interfering with multiple essential steps of the viral lifecycle.
This preventive drug could be a 'game changer' in ending the HIV ...
WEB3 days ago · Lenacapavir’s cost as HIV treatment in the United States in 2023 was $42,250 per new patient per year. Oral PrEP options, on the other hand, can cost less than $4 a month. Given the drug’s potential, Tremblay says that it is critical for access to be as widespread as possible. “The infrastructure needs to be in place to reach at-risk ...